Juschek Covid-19/ Influenza A+B Antigen Combo Rapid Self Test (Nasal Swab) 5 PackJuschek Covid 19 Influenza A+B Antigen Combo Rapid Self Test (Nasal Swab) 5 Pack Description JusChek COVID 19 Influenza A+B Combo Rapid Antigen Test Each pack contains: 5 x test cassettes 5 x sterile swabs 5 x extraction buffers Instruction manual Package insert COVID 19 rapid antigen test for unsupervised testing in the home Results in 10 minutes with high accuracy Easy to follow instructions included ARTG ID : 443914 This test may be used to detect

Juschek Covid-19/ Influenza A+B Antigen Combo Rapid Self Test (Nasal Swab) 5 Pack

Description

INTENDED USE

The SARS-CoV-2 and Influenza A+B Antigen Combo Rapid Test (Nasal Swab) is a single-use test kit
intended to detect the SARS-CoV-2, Influenza A and Influenza B virus that causes COVID-19 and/or
Influenza with self-collected nasal swab specimen. The test is intended for use in symptomatic individuals
who are suspected of being infected with COVID-19 within the first 7 days of symptom onset and / or
Influenza A+B within the first 4 days of symptom onset.
Results are for the detection of SARS-CoV-2 Nucleocapsid protein, Influenza A and Influenza B
nucleoproteins antigens. An antigen is generally detectable in upper respiratory specimens during the acute
phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient
history and other diagnostic information is necessary to determine infection status.
Positive results are indicative of the presence of SARS-CoV-2 and/or Influenza A+B. Individuals who test
positive should self-isolate and seek additional care from their healthcare provider. Positive results do not
rule out bacterial infection or co-infection with other viruses. Negative results do not preclude SARS-CoV-2
and/or Influenza A+B infection. Individuals who test negative and continue to experience COVID-like or
flu-like symptoms should seek follow up care from their healthcare provider.
The SARS-CoV-2 and Influenza A+B Antigen Combo Rapid Test (Nasal Swab) obtain a preliminary result
only, an aid diagnosis of COVID-19 and Influenza, the final confirmation should be based on clinical
diagnostic results.

SUMMARY
The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. People
are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of
infection; asymptomatic infected people can also be an infectious source. Based on the current
epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main
manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and
diarrhea are found in a few cases 1
.
Influenza (commonly known as ‘flu’) is a highly contagious, acute viral infection of the respiratory tract. It is a
communicable disease easily transmitted through the coughing and sneezing of aerosolized droplets
containing live virus 2
. Influenza outbreaks occur each year during the fall and winter months. Type A viruses
are typically more prevalent than type B viruses and are associated with most serious influenza epidemics,
while type B infections are usually milder.

Extra Information